TreeWAS – Variant ID: rs56181521

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
Chapter XIX Injury, poisoning and certain other consequences of external causes	1.000	0.000
# Top node	1.000	0.000
Chapter II Neoplasms	1.000	0.000
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	1.000	0.000
H25.1 Senile nuclear cataract	1.000	0.000
H25 Senile cataract	1.000	0.000
Chapter VII Diseases of the eye and adnexa	1.000	0.000
H25-H28 Disorders of lens	0.999	0.001
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.999	0.001
T36-T50 Poisoning by drugs, medicaments and biological substances	0.994	0.006
Chapter V Mental and behavioural disorders	0.992	0.008
C78.7 Secondary malignant neoplasm of liver	0.985	0.015
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.974	0.026
R41 Other symptoms and signs involving cognitive functions and awareness	0.973	0.027
Chapter XVIII Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified	0.973	0.027
R40-R46 Symptoms and signs involving cognition, perception, emotional state and behaviour	0.972	0.028
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.971	0.029
F30-F39 Mood [affective] disorders	0.970	0.030
S60-S69 Injuries to the wrist and hand	0.968	0.032
H25.8 Other senile cataract	0.965	0.035
C15-C26 Malignant neoplasms of digestive organs	0.963	0.037
R41.0 Disorientation, unspecified	0.960	0.040
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.958	0.042
F32 Depressive episode	0.955	0.045
C79 Secondary malignant neoplasm of other sites	0.950	0.050
T43.2 Other and unspecified antidepressants	0.948	0.052
F32.9 Depressive episode, unspecified	0.946	0.054
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.944	0.056
R41.3 Other amnesia	0.929	0.071
C77.2 Intra-abdominal lymph nodes	0.917	0.083
C71 Malignant neoplasm of brain	0.916	0.084
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.912	0.088
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.905	0.095
C80 Malignant neoplasm without specification of site	0.905	0.095
S10-S19 Injuries to the neck	0.899	0.101
H00-H06 Disorders of eyelid, lacrimal system and orbit	0.892	0.108
R41.8 Other and unspecified symptoms and signs involving cognitive functions and awareness	0.890	0.110
Chapter XX External causes of morbidity and mortality	0.884	0.116
F00-F09 Organic, including symptomatic, mental disorders	0.881	0.119
R47-R49 Symptoms and signs involving speech and voice	0.878	0.122
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.877	0.123
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.871	0.129
C25 Malignant neoplasm of pancreas	0.869	0.131
T66-T78 Other and unspecified effects of external causes	0.864	0.136
D37-D48 Neoplasms of uncertain or unknown behaviour	0.863	0.137
T08-T14 Injuries to unspecified part of trunk, limb or body region	0.860	0.140
R50-R69 General symptoms and signs	0.858	0.142
S80-S89 Injuries to the knee and lower leg	0.857	0.143
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.855	0.145
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.850	0.150
S90-S99 Injuries to the ankle and foot	0.850	0.150
S20-S29 Injuries to the thorax	0.849	0.151
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.848	0.152
C78.4 Secondary malignant neoplasm of small intestine	0.848	0.152
S61 Open wound of wrist and hand	0.847	0.153
R45 Symptoms and signs involving emotional state	0.845	0.155
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.844	0.156
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.843	0.157
T43.3 Phenothiazine antipsychotics and neuroleptics	0.841	0.159
C78.0 Secondary malignant neoplasm of lung	0.840	0.160
C64-C68 Malignant neoplasms of urinary tract	0.839	0.161
T51 Toxic effect of alcohol	0.839	0.161
R69 Unknown and unspecified causes of morbidity	0.838	0.162
S70-S79 Injuries to the hip and thigh	0.836	0.164
R47 Speech disturbances, not elsewhere classified	0.833	0.167
C77.8 Lymph nodes of multiple regions	0.831	0.169
C18 Malignant neoplasm of colon	0.831	0.169
R25-R29 Symptoms and signs involving the nervous and musculoskeletal systems	0.828	0.172
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.824	0.176
Chapter XIII Diseases of the musculoskeletal system and connective tissue	0.823	0.177
C21 Malignant neoplasm of anus and anal canal	0.822	0.178
S67 Crushing injury of wrist and hand	0.819	0.181
Chapter VI Diseases of the nervous system	0.818	0.182
S66 Injury of muscle and tendon at wrist and hand level	0.812	0.188
H46-H48 Disorders of optic nerve and visual pathways	0.809	0.191
F60-F69 Disorders of adult personality and behaviour	0.807	0.193
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis	0.806	0.194
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.805	0.195
F33 Recurrent depressive disorder	0.803	0.197
Chapter XV Pregnancy, childbirth and the puerperium	0.802	0.198
C51-C58 Malignant neoplasms of female genital organs	0.800	0.200
C71.0 Cerebrum, except lobes and ventricles	0.800	0.200
R56 Convulsions, not elsewhere classified	0.800	0.200
T51.0 Ethanol	0.799	0.201
R47.0 Dysphasia and aphasia	0.797	0.203
S40-S49 Injuries to the shoulder and upper arm	0.796	0.204
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.796	0.204
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.794	0.206
F03 Unspecified dementia	0.789	0.210
G90-G99 Other disorders of the nervous system	0.790	0.210
F32.2 Severe depressive episode without psychotic symptoms	0.789	0.211
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.789	0.211
C45 Mesothelioma	0.788	0.212
M20-M25 Other joint disorders	0.788	0.212
F20 Schizophrenia	0.788	0.212
R26 Abnormalities of gait and mobility	0.786	0.214
C16 Malignant neoplasm of stomach	0.784	0.215
T40.2 Other opioids	0.783	0.217
C25.2 Tail of pancreas	0.782	0.218
C80.0 Malignant neoplasm, primary site unknown, so stated	0.780	0.220
H02 Other disorders of eyelid	0.779	0.221
T20-T25 Burns and corrosions of external body surface, specified by site	0.778	0.222
S61.9 Open wound of wrist and hand, part unspecified	0.778	0.222
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.777	0.223
M86-M90 Other osteopathies	0.777	0.223
S81 Open wound of lower leg	0.773	0.227
S63 Dislocation, sprain and strain of joints and ligaments at wrist and hand level	0.771	0.229
H27 Other disorders of lens	0.771	0.229
F99-F99 Unspecified mental disorder	0.770	0.230
T78 Adverse effects, not elsewhere classified	0.766	0.234
C77.0 Lymph nodes of head, face and neck	0.765	0.235
R41.2 Retrograde amnesia	0.765	0.235
C80.9 Malignant neoplasm, unspecified	0.765	0.235
C69 Malignant neoplasm of eye and adnexa	0.761	0.239
C71.9 Brain, unspecified	0.761	0.239
G20-G26 Extrapyramidal and movement disorders	0.760	0.240
H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction	0.760	0.240
T14 Injury of unspecified body region	0.759	0.241
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.759	0.241
R56.8 Other and unspecified convulsions	0.758	0.242
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.758	0.242
C71.2 Temporal lobe	0.754	0.246
O60-O75 Complications of labour and delivery	0.750	0.250
R20-R23 Symptoms and signs involving the skin and subcutaneous tissue	0.749	0.251
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.748	0.252
C71.3 Parietal lobe	0.748	0.252
Chapter I Certain infectious and parasitic diseases	0.746	0.254
T50.9 Other and unspecified drugs, medicaments and biological substances	0.744	0.256
T79-T79 Certain early complications of trauma	0.743	0.257
M23 Internal derangement of knee	0.741	0.259
H10-H13 Disorders of conjunctiva	0.737	0.263
R45.1 Restlessness and agitation	0.736	0.264
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.735	0.265
O68 Labour and delivery complicated by foetal stress [distress]	0.733	0.267
R26.3 Immobility	0.733	0.267
T43.0 Tricyclic and tetracyclic antidepressants	0.731	0.269
S00-S09 Injuries to the head	0.731	0.269
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.730	0.269
S60 Superficial injury of wrist and hand	0.730	0.270
C56 Malignant neoplasm of ovary	0.730	0.270
S69 Other and unspecified injuries of wrist and hand	0.730	0.270
X60-X84 Intentional self-harm	0.729	0.270
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.726	0.274
S13 Dislocation, sprain and strain of joints and ligaments at neck level	0.724	0.276
F20.9 Schizophrenia, unspecified	0.723	0.277
R44 Other symptoms and signs involving general sensations and perceptions	0.723	0.277
G99 Other disorders of nervous system in diseases classified elsewhere	0.721	0.279
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.719	0.281
S10 Superficial injury of neck	0.719	0.281
S62 Fracture at wrist and hand level	0.719	0.281
H02.3 Blepharochalasis	0.718	0.282
T33-T35 Frostbite	0.717	0.283
T26-T28 Burns and corrosions confined to eye and internal organs	0.717	0.283
T00-T07 Injuries involving multiple body regions	0.717	0.283
Chapter XVI Certain conditions originating in the perinatal period	0.717	0.283
C76 Malignant neoplasm of other and ill-defined sites	0.717	0.283
C40-C41 Malignant neoplasms of bone and articular cartilage	0.717	0.283
H25.2 Senile cataract, morgagnian type	0.717	0.283
H28 Cataract and other disorders of lens in diseases classified elsewhere	0.716	0.283
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.716	0.284
C78.1 Secondary malignant neoplasm of mediastinum	0.716	0.284
Q80-Q89 Other congenital malformations	0.716	0.284
R52 Pain, not elsewhere classified	0.716	0.284
S64 Injury of nerves at wrist and hand level	0.715	0.285
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.713	0.287
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.712	0.287
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.712	0.287
T41 Poisoning by anaesthetics and therapeutic gases	0.712	0.287
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.712	0.287
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.712	0.287
T36 Poisoning by systemic antibiotics	0.712	0.287
S67.0 Crushing injury of thumb and other finger(s)	0.712	0.288
Chapter XXI Factors influencing health status and contact with health services	0.711	0.289
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.711	0.289
F70-F79 Mental retardation	0.711	0.289
H25.0 Senile incipient cataract	0.711	0.289
V20-V29 Motorcycle rider injured in transport accident	0.711	0.289
C77.1 Intrathoracic lymph nodes	0.710	0.290
M89 Other disorders of bone	0.710	0.290
S11 Open wound of neck	0.708	0.292
Y00-Y09 Assault	0.708	0.292
C79.6 Secondary malignant neoplasm of ovary	0.707	0.293
R46 Symptoms and signs involving appearance and behaviour	0.707	0.293
C18.9 Colon, unspecified	0.706	0.294
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.706	0.294
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.705	0.295
G25 Other extrapyramidal and movement disorders	0.705	0.295
W00-W19 Falls	0.705	0.295
R59 Enlarged lymph nodes	0.704	0.296
T46 Poisoning by agents primarily affecting the cardiovascular system	0.703	0.297
S27 Injury of other and unspecified intrathoracic organs	0.702	0.297
S12 Fracture of neck	0.702	0.298
S96 Injury of muscle and tendon at ankle and foot level	0.701	0.299
F80-F89 Disorders of psychological development	0.701	0.299
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.700	0.300
G93 Other disorders of brain	0.700	0.300
C67 Malignant neoplasm of bladder	0.700	0.300
T43.9 Psychotropic drug, unspecified	0.698	0.302
T43.8 Other psychotropic drugs, not elsewhere classified	0.698	0.302
T43.6 Psychostimulants with abuse potential	0.698	0.302
T43.4 Butyrophenone and thioxanthene neuroleptics	0.698	0.302
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.698	0.302
R41.1 Anterograde amnesia	0.698	0.302
R95-R99 Ill-defined and unknown causes of mortality	0.697	0.303
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands	0.697	0.303
R43 Disturbances of smell and taste	0.697	0.303
S20 Superficial injury of thorax	0.696	0.304
F38 Other mood [affective] disorders	0.695	0.305
F34 Persistent mood [affective] disorders	0.695	0.305
F30 Manic episode	0.695	0.305
F39 Unspecified mood [affective] disorder	0.695	0.305
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.695	0.305
S65 Injury of blood vessels at wrist and hand level	0.694	0.306
H55-H59 Other disorders of eye and adnexa	0.692	0.308
C21.1 Anal canal	0.691	0.309
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system	0.691	0.309
H02.1 Ectropion of eyelid	0.691	0.309
C17 Malignant neoplasm of small intestine	0.690	0.310
C23 Malignant neoplasm of gallbladder	0.690	0.310
C18.4 Transverse colon	0.689	0.311
W50-W64 Exposure to animate mechanical forces	0.688	0.311
C77.5 Intrapelvic lymph nodes	0.687	0.313
T14.0 Superficial injury of unspecified body region	0.687	0.313
T29-T32 Burns and corrosions of multiple and unspecified body regions	0.687	0.313
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.687	0.313
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.687	0.313
C70 Malignant neoplasm of meninges	0.687	0.313
T93 Sequelae of injuries of lower limb	0.685	0.315
F32.8 Other depressive episodes	0.685	0.315
T63 Toxic effect of contact with venomous animals	0.684	0.315
S81.8 Open wound of other parts of lower leg	0.683	0.316
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.683	0.317
H00 Hordeolum and chalazion	0.683	0.317
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.681	0.319
S91 Open wound of ankle and foot	0.680	0.320
F05 Delirium, not induced by alcohol and other psychoactive substances	0.679	0.321
O68.0 Labour and delivery complicated by foetal heart rate anomaly	0.679	0.321
R83-R89 Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis	0.679	0.321
S70 Superficial injury of hip and thigh	0.676	0.324
R52.9 Pain, unspecified	0.675	0.325
H05 Disorders of orbit	0.675	0.325
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.674	0.325
D46 Myelodysplastic syndromes	0.674	0.326
F60 Specific personality disorders	0.674	0.326
T98 Sequelae of other and unspecified effects of external causes	0.674	0.326
X50-X57 Overexertion, travel and privation	0.674	0.326
G99.2 Myelopathy in diseases classified elsewhere	0.672	0.328
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.672	0.328
C18.3 Hepatic flexure	0.672	0.328
Z30-Z39 Persons encountering health services in circumstances related to reproduction	0.672	0.328
M23.3 Other meniscus derangements	0.670	0.330
H43-H45 Disorders of vitreous body and globe	0.670	0.330
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.670	0.330
S66.1 Injury of flexor muscle and tendon of other finger at wrist and hand level	0.669	0.331
O10-O16 Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium	0.668	0.332
G96 Other disorders of central nervous system	0.668	0.332
C25.0 Head of pancreas	0.667	0.333
T40.6 Other and unspecified narcotics	0.667	0.333
O68.1 Labour and delivery complicated by meconium in amniotic fluid	0.667	0.333
F32.1 Moderate depressive episode	0.666	0.334
Chapter XXII Codes for special purposes	0.665	0.334
H01 Other inflammation of eyelid	0.665	0.335
R26.2 Difficulty in walking, not elsewhere classified	0.664	0.336
T78.2 Anaphylactic shock, unspecified	0.664	0.336
C15 Malignant neoplasm of oesophagus	0.663	0.337
X58-X59 Accidental exposure to other and unspecified factors	0.662	0.338
T59 Toxic effect of other gases, fumes and vapours	0.662	0.338
C26 Malignant neoplasm of other and ill-defined digestive organs	0.661	0.339
C18.5 Splenic flexure	0.661	0.339
R68 Other general symptoms and signs	0.660	0.339
H47 Other disorders of optic [2nd] nerve and visual pathways	0.660	0.340
M24 Other specific joint derangements	0.659	0.341
C18.1 Appendix	0.659	0.341
M87 Osteonecrosis	0.658	0.342
C45.9 Mesothelioma, unspecified	0.658	0.342
R61 Hyperhidrosis	0.657	0.342
C71.8 Overlapping lesion of brain	0.657	0.343
C71.7 Brain stem	0.657	0.343
C71.6 Cerebellum	0.657	0.343
C71.5 Cerebral ventricle	0.657	0.343
C71.4 Occipital lobe	0.657	0.343
Q38-Q45 Other congenital malformations of the digestive system	0.655	0.345
T65 Toxic effect of other and unspecified substances	0.654	0.346
T62 Toxic effect of other noxious substances eaten as food	0.654	0.346
T61 Toxic effect of noxious substances eaten as seafood	0.654	0.346
T60 Toxic effect of pesticides	0.654	0.346
T57 Toxic effect of other inorganic substances	0.654	0.346
T56 Toxic effect of metals	0.654	0.346
T54 Toxic effect of corrosive substances	0.654	0.346
T53 Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbone	0.654	0.346
T52 Toxic effect of organic solvents	0.654	0.346
T64 Toxic effect of aflatoxin and other mycotoxin food contaminants	0.654	0.346
T58 Toxic effect of carbon monoxide	0.654	0.346
T55 Toxic effect of soaps and detergents	0.654	0.346
F01 Vascular dementia	0.654	0.346
X40-X49 Accidental poisoning by and exposure to noxious substances	0.654	0.346
H18 Other disorders of cornea	0.653	0.347
T42.4 Benzodiazepines	0.653	0.347
C48.2 Peritoneum, unspecified	0.652	0.347
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.652	0.348
C16.0 Cardia	0.652	0.348
S02 Fracture of skull and facial bones	0.652	0.348
B35-B49 Mycoses	0.651	0.349
T47.1 Other antacids and anti-gastric-secretion drugs	0.651	0.349
F06 Other mental disorders due to brain damage and dysfunction and to physical disease	0.651	0.349
F32.0 Mild depressive episode	0.650	0.349
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.649	0.351
C46 Kaposi's sarcoma	0.649	0.351
H52 Disorders of refraction and accommodation	0.648	0.352
V40-V49 Car occupant injured in transport accident	0.647	0.353
Z36 Antenatal screening	0.647	0.353
S61.0 Open wound of finger(s) without damage to nail	0.647	0.353
S49 Other and unspecified injuries of shoulder and upper arm	0.647	0.353
S83 Dislocation, sprain and strain of joints and ligaments of knee	0.647	0.353
C49 Malignant neoplasm of other connective and soft tissue	0.647	0.353
R45.8 Other symptoms and signs involving emotional state	0.646	0.353
C45.0 Mesothelioma of pleura	0.646	0.354
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.645	0.354
F33.0 Recurrent depressive disorder, current episode mild	0.645	0.355
S41 Open wound of shoulder and upper arm	0.645	0.355
S17 Crushing injury of neck	0.645	0.355
S15 Injury of blood vessels at neck level	0.645	0.355
S14 Injury of nerves and spinal cord at neck level	0.645	0.355
S18 Traumatic amputation at neck level	0.645	0.355
S16 Injury of muscle and tendon at neck level	0.645	0.355
F33.1 Recurrent depressive disorder, current episode moderate	0.644	0.356
S19 Other and unspecified injuries of neck	0.644	0.356
M21 Other acquired deformities of limbs	0.643	0.356
C71.1 Frontal lobe	0.642	0.358
C21.0 Anus, unspecified	0.642	0.358
S36 Injury of intra-abdominal organs	0.641	0.358
R57 Shock, not elsewhere classified	0.641	0.358
S63.5 Sprain and strain of wrist	0.641	0.359
H06 Disorders of lachrymal system and orbit in diseases classified elsewhere	0.640	0.359
G97 Postprocedural disorders of nervous system, not elsewhere classified	0.640	0.360
S80 Superficial injury of lower leg	0.640	0.360
C25.9 Pancreas, unspecified	0.640	0.360
H03 Disorders of eyelid in diseases classified elsewhere	0.639	0.361
H02.6 Xanthelasma of eyelid	0.639	0.361
S66.8 Injury of other muscles and tendons at wrist and hand level	0.639	0.361
S30 Superficial injury of abdomen, lower back and pelvis	0.638	0.362
G25.8 Other specified extrapyramidal and movement disorders	0.637	0.363
S90 Superficial injury of ankle and foot	0.637	0.363
C64 Malignant neoplasm of kidney, except renal pelvis	0.635	0.365
X20-X29 Contact with venomous animals and plants	0.634	0.366
Y35-Y36 Legal intervention and operations of war	0.634	0.366
Y10-Y34 Event of undetermined intent	0.634	0.366
X85-X99 Assault	0.634	0.366
X30-X39 Exposure to forces of nature	0.634	0.366
X10-X19 Contact with heat and hot substances	0.634	0.366
X00-X09 Exposure to smoke, fire and flames	0.634	0.366
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.634	0.366
W75-W84 Other accidental threats to breathing	0.634	0.366
W65-W74 Accidental drowning and submersion	0.634	0.366
V98-V99 Other and unspecified transport accidents	0.634	0.366
V95-V97 Air and space transport accidents	0.634	0.366
V90-V94 Water transport accidents	0.634	0.366
V70-V79 Bus occupant injured in transport accident	0.634	0.366
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.634	0.366
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.634	0.366
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.634	0.366
V01-V09 Pedestrian injured in transport accident	0.634	0.366
Y42.7 Androgens and anabolic congeners	0.634	0.366
H16 Keratitis	0.633	0.367
M23.33 Other meniscus derangements (Medial collateral ligament or Other and unspecified medial meniscus)	0.632	0.368
F20.0 Paranoid schizophrenia	0.632	0.368
F07 Personality and behavioural disorders due to brain disease, damage and dysfunction	0.632	0.368
F02 Dementia in other diseases classified elsewhere	0.632	0.368
F09 Unspecified organic or symptomatic mental disorder	0.632	0.368
F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances	0.632	0.368
H02.2 Lagophthalmos	0.631	0.369
O69 Labour and delivery complicated by umbilical cord complications	0.631	0.369
R23 Other skin changes	0.631	0.369
R48 Dyslexia and other symbolic dysfunctions, not elsewhere classified	0.629	0.371
T78.4 Allergy, unspecified	0.629	0.371
S73 Dislocation, sprain and strain of joint and ligaments of hip	0.629	0.371
Y57 Other and unspecified drugs and medicaments	0.629	0.371
S31 Open wound of abdomen, lower back and pelvis	0.627	0.373
G20 Parkinson's disease	0.626	0.374
T15-T19 Effects of foreign body entering through natural orifice	0.626	0.374
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.624	0.375
T40.8 Lysergide [LSD]	0.624	0.375
T40.7 Cannabis (derivatives)	0.624	0.375
T40.5 Cocaine	0.624	0.375
T40.3 Methadone	0.624	0.375
T40.1 Heroin	0.624	0.375
T40.0 Opium	0.624	0.375
M33 Dermatopolymyositis	0.624	0.376
C65 Malignant neoplasm of renal pelvis	0.624	0.376
V80-V89 Other land transport accidents	0.624	0.376
S81.0 Open wound of knee	0.624	0.376
O71 Other obstetric trauma	0.624	0.376
C25.8 Overlapping lesion of pancreas	0.623	0.377
C25.7 Other parts of pancreas	0.623	0.377
C25.4 Endocrine pancreas	0.623	0.377
C25.3 Pancreatic duct	0.623	0.377
C25.1 Body of pancreas	0.623	0.377
R22 Localised swelling, mass and lump of skin and subcutaneous tissue	0.623	0.377
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.622	0.378
V10-V19 Pedal cyclist injured in transport accident	0.622	0.378
S89 Other and unspecified injuries of lower leg	0.621	0.379
Q00-Q07 Congenital malformations of the nervous system	0.620	0.380
T43.5 Other and unspecified antipsychotics and neuroleptics	0.620	0.380
T90 Sequelae of injuries of head	0.620	0.380
C69.3 Choroid	0.620	0.380
B00-B09 Viral infections characterized by skin and mucous membrane lesions	0.620	0.380
T23 Burn and corrosion of wrist and hand	0.619	0.380
R47.8 Other and unspecified speech disturbances	0.619	0.381
T75 Effects of other external causes	0.619	0.381
T74 Maltreatment syndromes	0.619	0.381
T73 Effects of other deprivation	0.619	0.381
T70 Effects of air pressure and water pressure	0.619	0.381
T69 Other effects of reduced temperature	0.619	0.381
T67 Effects of heat and light	0.619	0.381
T71 Asphyxiation	0.619	0.381
T68 Hypothermia	0.619	0.381
T66 Unspecified effects of radiation	0.619	0.381
D42 Neoplasm of uncertain or unknown behaviour of meninges	0.618	0.381
D40 Neoplasm of uncertain or unknown behaviour of male genital organs	0.618	0.381
H04 Disorders of lachrymal system	0.618	0.382
Z00-Z13 Persons encountering health services for examination and investigation	0.618	0.382
C97 Malignant neoplasms of independent (primary) multiple sites	0.618	0.382
M23.8 Other internal derangements of knee	0.618	0.382
G00-G09 Inflammatory diseases of the central nervous system	0.617	0.383
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms	0.617	0.383
T13 Other injuries of lower limb, level unspecified	0.616	0.383
T11 Other injuries of upper limb, level unspecified	0.616	0.383
T09 Other injuries of spine and trunk, level unspecified	0.616	0.383
T12.X1 Fracture of lower limb, level unspecified (open)	0.616	0.383
T12.X0 Fracture of lower limb, level unspecified (closed)	0.616	0.383
T12 Fracture of lower limb, level unspecified	0.616	0.383
T10.X1 Fracture of upper limb, level unspecified (open)	0.616	0.383
T10.X0 Fracture of upper limb, level unspecified (closed)	0.616	0.383
T10 Fracture of upper limb, level unspecified	0.616	0.383
T08.X1 Fracture of spine, level unspecified (open)	0.616	0.383
T08.X0 Fracture of spine, level unspecified (closed)	0.616	0.383
T08 Fracture of spine, level unspecified	0.616	0.383
S79 Other and unspecified injuries of hip and thigh	0.616	0.384
S60.9 Superficial injury of wrist and hand, unspecified	0.616	0.384
R65 Systemic Inflammatory Response Syndrome [SIRS]	0.615	0.384
R62 Lack of expected normal physiological development	0.615	0.384
R64 Cachexia	0.615	0.384
R58 Haemorrhage, not elsewhere classified	0.615	0.384
S88 Traumatic amputation of lower leg	0.614	0.386
S87 Crushing injury of lower leg	0.614	0.386
S86 Injury of muscle and tendon at lower leg level	0.614	0.386
S85 Injury of blood vessels at lower leg level	0.614	0.386
S84 Injury of nerves at lower leg level	0.614	0.386
C79.8 Secondary malignant neoplasm of other specified sites	0.614	0.386
H20 Iridocyclitis	0.613	0.387
M60-M63 Disorders of muscles	0.613	0.387
S71 Open wound of hip and thigh	0.612	0.388
F99 Mental disorder, not otherwise specified	0.612	0.388
M89.9 Disorder of bone, unspecified	0.612	0.388
B20-B24 Human immunodeficiency virus [HIV] disease	0.611	0.389
M89.8 Other specified disorders of bone	0.611	0.389
Y48 Anaesthetics and therapeutic gases	0.610	0.390
F25 Schizoaffective disorders	0.610	0.390
F28 Other nonorganic psychotic disorders	0.610	0.390
F24 Induced delusional disorder	0.610	0.390
F21 Schizotypal disorder	0.610	0.390
S72 Fracture of femur	0.610	0.390
S99 Other and unspecified injuries of ankle and foot	0.609	0.390
S98 Traumatic amputation of ankle and foot	0.609	0.390
S97 Crushing injury of ankle and foot	0.609	0.390
S95 Injury of blood vessels at ankle and foot level	0.609	0.390
S94 Injury of nerves at ankle and foot level	0.609	0.390
S93 Dislocation, sprain and strain of joints and ligaments at ankle and foot level	0.609	0.390
S28 Crushing injury of thorax and traumatic amputation of part of thorax	0.609	0.391
S26 Injury of heart	0.609	0.391
S25 Injury of blood vessels of thorax	0.609	0.391
S24 Injury of nerves and spinal cord at thorax level	0.609	0.391
S23 Dislocation, sprain and strain of joints and ligaments of thorax	0.609	0.391
S21 Open wound of thorax	0.609	0.391
T50.8 Diagnostic agents	0.608	0.392
T50.7 Analeptics and opioid receptor antagonists	0.608	0.392
T50.6 Antidotes and chelating agents, not elsewhere classified	0.608	0.392
T50.5 Appetite depressants	0.608	0.392
T50.4 Drugs affecting uric acid metabolism	0.608	0.392
T50.3 Electrolytic, caloric and water-balance agents	0.608	0.392
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.608	0.392
T50.1 Loop [high-ceiling] diuretics	0.608	0.392
T50.0 Mineralocorticoids and their antagonists	0.608	0.392
S61.7 Multiple open wounds of wrist and hand	0.607	0.392
W20-W49 Exposure to inanimate mechanical forces	0.607	0.393
Y51 Drugs primarily affecting the autonomic nervous system	0.606	0.394
G80-G83 Cerebral palsy and other paralytic syndromes	0.606	0.394
R45.7 State of emotional shock and stress, unspecified	0.606	0.394
R45.6 Physical violence	0.606	0.394
R45.5 Hostility	0.606	0.394
R45.4 Irritability and anger	0.606	0.394
R45.3 Demoralisation and apathy	0.606	0.394
R45.2 Unhappiness	0.606	0.394
R45.0 Nervousness	0.606	0.394
G93.6 Cerebral oedema	0.606	0.394
B99-B99 Other infectious diseases	0.605	0.395
T95 Sequelae of burns, corrosions and frostbite	0.605	0.395
T94 Sequelae of injuries involving multiple and unspecified body regions	0.605	0.395
T97 Sequelae of toxic effects of substances chiefly nonmedicinal as to source	0.605	0.395
T96 Sequelae of poisoning by drugs, medicaments and biological substances	0.605	0.395

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations